China’s Emerging Global Vaccine Footprint
While demand for COVID-19 vaccines may be decreasing, the pandemic highlighted the long-term importance of boosting local vaccine manufacturing in developing countries. China’s role as a key vaccine donor and provider during the pandemic has positioned it to support this new agenda, making it a critical emerging player in the global vaccine manufacturing landscape. As a mission-driven consultancy looking to encourage China’s engagement in global health, Bridge Consulting aims to identify and drive China’s involvement in this important endeavor.
Article Series: Towards Africa's Local Vaccine Manufacturing
Joint Vaccine Production
RecBio signed a strategic partnership agreement with Saudi Arabian pharma SPIMACO for the licensing, supply, and technology transfer of HPV 9-valent vaccines. This one year term will involve the import of finished and ready-to-fill bulk forms of the vaccine, followed by local filling and packaging processes overseen by SPIMACO, and a technology transfer initiative, leveraging Recbio’s expertise, knowledge, and experience to facilitate local manufacturing of the HPV-9 vaccine — Zawya
Africa CDC and CEPI are hosting the African Vaccine Manufacturing Supply Chain Forum from Jan 31 to Feb 2, discussing ways to carve out a robust supply chain for vaccine manufacturing across the continent — Africa CDC